Psychedelic Spotlight News

Quebec Breaks New Ground in Psychedelic Therapy: Patients Treated Together at Hope & Cope Cancer Wellness Centre

Two cancer patients received simultaneous psilocybin-assisted therapy (PAT) treatment on September 22nd, 2023, at The Hope & Cope Wellness Centre in Montréal, under the care of Dr. Houman Farzin. This session marks Quebec’s first-ever legal group experience with psilocybin, access to which was granted through Health Canada's Special Access Program (SAP) and with medicines donated by Psygen and Filament Health.

The Biggest Psychedelic News This Week: November 6 – 10

Policy, Research

While everyone was preparing to head to Wonderland Miami, the psychedelic space saw a week full of debates! From the FDA's recommendation to limit psychological support in clinical trials, to debates over the necessity of the 'trip' in the psychedelic experience, to whether microdosing's benefits are influenced by expectancy bias.

FDA Sparks Debate Over the Role of Psychological Support In Psychedelic Clinical Trials

Culture

While clinical research furthers its quest in proving psychedelics’ potential in treating a variety of psychiatric disorders, the debate now is the importance of psychological support in trials investigating psychedelic-assisted therapy.

NeuroDirect topical ketamine formulation

Topical Ketamine: A Game-Changer for PTSD?

Business, Research

Anecdotal research suggests NeuroDirect topical ketamine relieves PTSD symptoms in minutes. But the mechanism of action is unclear.

Is Ibogaine & 5-MeO-DMT the ultimate 1-2 punch for PTSD? This study suggests that it might be for Special Operation Forces Veterans

Research

The potential benefits of combined ibogaine & 5-MeO-DMT assisted therapy include, significant and very large improvements in self reported symptoms of PTSD, depression, anxiety, insomnia severity, and anger, a significant and medium reduction in suicidal ideation, and more.

SAiD: Spiritual Aid in Dying: Psychedelics, MAiD, and Fully Informed Consent

OPINION

If our current methods, practices, and thoughts about Hospice and Palliative Care, and end-of-life attitudes and knowledge in general, would change, MAiD wouldn’t be necessary in most cases, but it should be an accessible option and choice for everyone that we then don’t need to exercise. Shifting the focus to the surrounding suffering would, in-and-of itself, present many different options.

TREAT California Withdraws 2024 Ballot Initiative Efforts, Redirects Focus to TREAT Humanity

Policy

TREAT California, a citizen-driven ballot initiative to fund research and access for psychedelic medicines to treat mental health, is withdrawing from the signature-gathering process.

The Biggest Psychedelic News This Week: Oct 30th – Nov 3rd

Policy, Research

While unprecedented positive results provide further proof of psilocybin's anti-depressive effects, other studies investigate the long-term adverse effects of challenging trips. Meanwhile, the DEA wants to increase the manufacturing of certain psychedelics yet again as more psychedelic dispensaries are getting raided in Canada.

How to Make Blue Honey: Step-By-Step Guide

Diving into Blue Honey: a Roadmap to a Sweet Psychedelic Journey

Beginners, Education

Blue honey, or honey infused with psilocybin mushrooms, offers a delicious solution to mushroom storage and consumption. Here's a comprehensive guide on how to make psychedelic honey, how to dose it, and where to store it.

African psychedelic and psychoactive plants

Africa’s Forgotten Cradle of Psychoactive Plants – Global Psychoactive Plant Use Research

Culture, Research

Documenting over 300 species of psychoactive plants being used for psychedelic and psychoactive purposes in African traditional medicine; the first comprehensive inventory of psychoactive plants from the continent. This includes plants with sedative, stimulant, memory enhancing and visionary entheogenic uses amongst others, for treating various conditions such as; Alzheimer's, dementia, insomnia, epilepsy, stress, anxiety and depression.